| |
|
|
|
Evoke Pharma  
|
|
2.95 -0.16 (-0.05%) |
02-26 16:00 |
|
Open: |
3.19 |
Pre close: |
3.11 |
Target:
|
4.58
|
|
High: |
3.19 |
Low: |
2.9 |
Resistance:
|
3.93
4.80
|
|
Volume: |
396,451 |
Market Cap: |
93M |
Support:
|
2.51
2.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.14
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
3.24  |
Signal(12,26,9): |
0.13 |
|
MA(100): |
3.34 |
Stochastic Oscillator |
%K(14,3):
|
15.00 |
|
MA(250): |
3.08 |
%D(3): |
21.30 |
|
Average Volume(K) |
3-Month: |
63145
|
52-Week |
High:
|
6.06 |
|
10-Days: |
52589 |
Low: |
0.79 |
|
RSI |
RSI(14):
|
45.59 |
Change(%): |
128.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.493 |
Return on Equity (ttm) |
-757.3 |
Shares Out. (M) |
31.39 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-108.9 |
Shares Float (M) |
22.43 |
|
EPS Est. Next Year |
-0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.92 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.97 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
869 |
|
Book Value (p.s.) |
-0.070 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.98 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-42.14 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.07 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.51 |
P/CF |
-15.26 |
|
|
|
|
|
|
